In brief, TrkB signaling seems to be more active in slow than in fast muscles, in accordance with higher neurotrophic factors consumption and following their resistance to fatigue and vulnerability to neurodegenerative diseases such as ALS. This evidence concerns the gene NTRK2 and neurodegenerative disease.